Shasun Pharma

Chennai, India Founded: 1976 • Age: 50 yrs Acquired By Strides Arcolab
Company manufacturing and offering CDMO services for APIs, intermediates and solid dosage forms
Annual revenue - Latest available
Total funding $10.0M 1 rounds
Employees 661 Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Shasun Pharma

Shasun Pharma is a company based in Chennai (India) founded in 1976 by Abhaya Kumar Srisrimal was acquired by Strides Arcolab in September 2014. Shasun Pharma has raised $10 million across 1 funding round from investors including Orbimed and Strides Arcolab. The company has 661 employees as of April 09, 2024. Shasun Pharma has completed 1 acquisition, including Vanquishheadacherelief. Shasun Pharma operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

  • Headquarter Chennai, India
  • Employees 661 as on 09 Apr, 2024
  • Founders Abhaya Kumar Srisrimal
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Shasun Pharmaceuticals Limited
  • Date of Incorporation 19 Apr, 1976
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $10 M (USD)

    in 1 rounds

  • Latest Funding Round
    $10 M (USD), Series A

    Feb 28, 2012

  • Investors
    Orbimed

    & 1 more

  • Employee Count
    661

    as on Apr 09, 2024

  • Investments & Acquisitions
  • Acquired by
    Strides Arcolab

    (Sep 29, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Shasun Pharma

Shasun Pharma has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Shasun Pharma

Shasun Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed and Strides Arcolab.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Locked Locked Locked
Manufacturer of IP-led niche finished dosage formulations and soft gelatin capsules
Locked Locked Locked
Premium access

Investor details for Shasun Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Shasun Pharma

Shasun Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vanquishheadacherelief.

Investments
Premium access

Investment portfolio details for Shasun Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Over-the-counter pain relief medications are manufactured for various minor aches.
Locked Locked 0 Locked
Premium access

Complete acquisition details for Shasun Pharma

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Shasun Pharma

Premium access

Detailed financials for Shasun Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Shasun Pharma Comparisons

Shasun Pharma Primary company
Description
Company manufacturing and offering CDMO services for APIs, i...
Location
Chennai, India
Founded Year
1976
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
661
As of 2024
Premium access

Peer comparison for Shasun Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Shasun Pharma

Shasun Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated CDMO services for biopharma R&D and manufacturing are offered.
Locked Locked Locked
APIs manufacturing and formulation services are provided in therapeutic segments.
Locked Locked Locked
APIs and enzymes are manufactured through fermentation by the CDMO.
Locked Locked Locked
APIs and finished products are developed and manufactured.
Locked Locked Locked
Generic biocatalytic solutions are provided for pharmaceutical applications.
Locked Locked Locked
APIs and peptides are developed and manufactured by Asymchem.
Premium access

Detailed competitors of Shasun Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Shasun Pharma

Premium access

Complete news archive for Shasun Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shasun Pharma

Shasun Pharma was founded in 1976 and raised its 1st funding round 36 years after it was founded.

Shasun Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

Shasun Pharma is a funded company, having raised a total of $10M across 1 funding round to date.

As of Apr 09, 2024, the latest employee count at Shasun Pharma is 661.

Shasun Pharmaceuticals makes drug ingredients and finished medicines, as well as provides contract research and manufacturing services. It supplies to North America, Europe, Asia and Latin America. The company offers formulation and generic manufacturing services at its Indian sites together with contract research and manufacturing services for APIs (Active Pharmaceutical Ingredients) in India and the UK. Its service portfolio includes analytical method development and validation, scale-up technology transfer, clinical supplies manufacturing and full-scale commercial manufacturing of oral solid dosage forms. The company claims to be one of the largest global producers of generic Ibuprofen and also to have expertise in enteric coating excipients. Shasuns manufacturing facilities are certified by US FDA, MHRA, ANVISA (Brazil) and COFEPRIS (Mexico). Shasun has acquired (Rhodia Pharma Solutions business, France) and formed JV alliances (Nanoparticle Biochem, US, and Alivira Animal Health ) with foreign and domestic partners. The company went public in 1996 and merged with Strides Arcolab in Nov 2015.

Shasun Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.

Shasun Pharma has made 1 acquisition, including Vanquishheadacherelief.

Shasun Pharma has 2 investors. Key investors include Orbimed, and Strides Arcolab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available